Komori
Share Issuance and Disposal4575CanBas Co.,Ltd.Pharmaceuticals

Notice Regarding the Substantial Exercise of the 22nd Stock Acquisition Rights (with Exercise Price Adjustment Clause)

For the 22nd Stock Acquisition Rights, 1,135,500 shares were delivered from 2 to 19 November 2026, and 11,350 rights, equivalent to 56.75% of the total issued rights, were exercised. The number of unexercised stock acquisition rights decreased from 20,000 to 8,650.

Worth reading
72In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
1135500
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Report on the Large-Scale Exercise of Stock Acquisition Rights with Exercise Price Adjustment Provisions

発行・処分する株式数1,135,500Shares

1,135,500 new shares (no treasury shares transferred)

Existing Shares and Increase
+5.76%Rate of increase
19,713,655 shares20,849,155Shares

The number of shares delivered since the beginning of the month is 1,135,500, equivalent to approximately 5.76% of the 19,713,655 shares outstanding at the end of the previous month.

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Terms of the stock acquisition rights
Exercise price
With exercise price adjustment provisions. The exercise price for each exercise date is stated in the range of ¥612 to ¥689. Adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 20,000 rights; exercised since the beginning of the month: 11,350 rights; unexercised balance as of the current date: 8,650 rights
Most recent equity financing
Timing 30 October 2026 / Type Issuance of the 22nd Series of Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
Details of issuance or disposal
ItemDetails
Type of issuance or disposalReport on the Large-Scale Exercise of Stock Acquisition Rights with Exercise Price Adjustment Provisions
Number of shares to be issued or disposed of1,135,500 new shares (no treasury shares transferred)
Dilution RateThe number of shares delivered since the beginning of the month is 1,135,500, equivalent to approximately 5.76% of the 19,713,655 shares outstanding at the end of the previous month.
Total number of issued shares19,713,655 shares (as of the end of the previous month) → 20,849,155 shares (assuming the delivered shares are simply added)(Approximately 5.76%)
Exercise priceWith exercise price adjustment provisions. The exercise price for each exercise date is stated in the range of ¥612 to ¥689. Adjustment floor: Not disclosed
Number of Stock Acquisition RightsTotal issued: 20,000 rights; exercised since the beginning of the month: 11,350 rights; unexercised balance as of the current date: 8,650 rights
Most recent equity financingTiming 30 October 2026 / Type Issuance of the 22nd Series of Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To report the status of the large-scale exercise. No other reason is stated in the document.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Substantial Exercise of the 22nd Stock Acquisition Rights (with Exercise Price Adjustment Clause) | CanBas Co.,Ltd. (4575) timely disclosure | Komori